Ga-68 Dolacga

N/A

Report date: 2025/11/27 15:48:02
NME

Base Information

Drug NameGa-68 Dolacga
Drug Alias NameGa68-DolacgaGa68-Dolacga
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionPositron-emission tomography enhancersRadionuclide imaging enhancersEmission-computed tomography enhancers +[4] 
TargetsAsialoglycoprotein receptor
Therapy Area/IndicationsLiver NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaiwan Institute Of Nuclear Energy Research (Iner)
China Registration ClassN/A

Develop Information

Active CompaniesNational Atomic Research Institute, TaiwanInstitute Of Nuclear Energy Research, Taiwan
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A